Immunome Inc. (IMNM) Social Stream
IMMUNOME INC (IMNM) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering IMMUNOME INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-10-29 | 2 | $35.001 | $21 | $28 | $7.8 | 258.97% |
| 2021-11-16 | 2 | $35 | $21 | $28 | $7.8 | 258.97% |
| 2022-01-11 | 2 | $33 | $21 | $27 | $7.8 | 246.15% |
| 2022-03-30 | 2 | $16 | $16 | $16 | $7.8 | 105.13% |
| 2022-04-01 | 2 | $33 | $16 | $24.5 | $7.8 | 214.1% |
| 2022-04-25 | 2 | $16 | $14 | $15 | $7.8 | 92.31% |
| 2022-05-09 | 2 | $16 | $14.001 | $15 | $7.8 | 92.31% |
| 2022-08-08 | 2 | $14.001 | $9 | $11.5 | $7.8 | 47.44% |
| 2023-03-20 | 2 | $9 | $8 | $8.5 | $7.8 | 8.97% |
| 2023-05-09 | 1 | $8 | $8 | $8 | $7.8 | 2.56% |
| 2023-05-15 | 2 | $8 | $8 | $8 | $7.8 | 2.56% |
| NA | 1 | $NA | $NA | $NA | $7.8 | NA% |
The Trend in the Analyst Price Target
IMNM's average price target has moved down $15 over the prior 31 months.
IMNM reports an average of 36.21% for its upside potential over the past 59 days.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-03-17 | 1 | 8 | 8 | 8.0 | 5.69 | 40.6% |
| 2023-03-20 | 2 | 9 | 8 | 8.5 | 5.65 | 50.44% |
| 2023-03-20 | 2 | 8 | 8 | 8.0 | 5.65 | 41.59% |
| 2023-05-09 | 1 | 8 | 8 | 8.0 | 6.25 | 28% |
| 2023-05-09 | 2 | 8 | 8 | 8.0 | 6.25 | 28% |
IMNM Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 2 | 0 | 0 | 0 | 0 | 2 |
The Trend in the Broker Recommendations
IMNM's average broker recommendation rating improved by 0 over the prior 26 weeks.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- IMNM has a greater number of analysts covering the stock than 29% of all US stocks.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, IMMUNOME INC's variance in analysts' estimates is lower than -93.14% of them.
- In terms of how IMMUNOME INC fares relative to Healthcare stocks, note that its average analyst price target is greater than 318.16% of that group.
- IMMUNOME INC's upside potential (average analyst target price relative to current price) is greater than 494.93% of stocks in the small market cap category.
Stocks similar to IMMUNOME INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are KRON, SPRB, and FHTX.
View All Top Stocks by Price Target
Is IMNM a Buy, Hold or Sell? See the POWR Ratings now!